Alzheimer Society of Canada stresses on early diagnosis of dementia

NewsGuard 100/100 Score

Global community promoting importance of early diagnosis

Startling new statistics on the worldwide prevalence of Alzheimer's disease and related dementias are being released today as countries across the globe join together in recognition of World Alzheimer's Day.

According to the World Alzheimer Report, released today by Alzheimer's Disease International (ADI), an estimated 35.6 million people worldwide will be living with dementia in 2010. This is a 10 per cent increase over previous global dementia prevalence reported in 2005 in The Lancet. According to the new report, dementia prevalence will nearly double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050.

"The information in the 2009 World Alzheimer Report makes it clear that the crisis of dementia cannot be ignored," says Debbie Benczkowski, Interim CEO of the Alzheimer Society of Canada. "Unchecked, dementia will impose enormous burdens on individuals, families, health care infrastructures, and global economy."

The report also focuses on the impact of dementia. For example, statistics cited in the new report suggest that 40 to 75 per cent of caregivers have significant psychological illness as a result of their caregiving, and 15 to 32 per cent have depression. Challenges faced by governments and health care systems worldwide are also outlined, and eight global recommendations are offered based on report findings.

This international report is being delivered today amongst a global message of Diagnosing Dementia: See it Sooner. The Alzheimer Society is joining Alzheimer organizations across the world, speaking out about the importance of early diagnosis.

"Early diagnosis is an essential first step towards receiving appropriate help and support. Delay in diagnosis means that people with dementia and their caregivers suffer unnecessarily from uncertainty about what is happening, are deprived of the treatment and care they need, and are unable to begin planning for the future," says Dr. Jack Diamond, Scientific Director of the Alzheimer Society of Canada.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice